[webinar] dystance 51, a phase 2/3 clinical trial of investigational suvodirsen in duchenne
Published 5 years ago • 615 plays • Length 47:14Download video MP4
Download video MP3
Similar videos
-
29:47
webinar: update on investigational suvodirsen in duchenne muscular dystrophy - dec 2019
-
52:49
[webinar] idebenone clinical trials in duchenne - march 2017
-
48:50
webinar: dyne therapeutics — advancing force in the pursuit of transformative therapies (april 2023)
-
59:41
[webinar] vamorolone clinical trials in duchenne - january 2019
-
1:00:59
webinar: advancing dyne-251 - an investigational medicine for duchenne to deliver for patients
-
42:18
webinar: dyne therapeutics update on dyne-251 (july 2022)
-
43:53
[webinar] movedmd: a clinical trial of edasalonexent (cat-1004) in duchenne - june 2016
-
59:04
[webinar] results from phase i/ii hope clinical trial of cap-1002 - april 2017
-
23:09
foundations of drug development: participation in duchenne clinical trials
-
56:21
[webinar] domagrozumab as a potential treatment for duchenne - may 2019
-
53:22
webinar: edgewise therapeutics - a novel approach to protect muscle in duchenne & becker (oct 2022)
-
1:09:05
[webinar] hope-2 duchenne clinical trial – capricor – july 2018
-
1:13:49
hope-duchenne trial - capricor therapeutics [january 2016 webinar]
-
47:14
cat-1004 (catabasis) clinical trial webinar [may 2015]
-
58:18
[webinar] summit's utrophin modulation program - january 2017
-
1:04:24
webinar: viltepso - a treatment option for patients amenable to exon 53 skipping (april 2021)
-
54:42
webinar: ataluren update with ptc
-
56:00
[webinar] santhera update to the duchenne community - may 2019
-
1:05:33
clinical trials in duchenne: a behind the scenes look (december 2013)